The use of regorafenib for patients with refractory metastatic colorectal cancer in clinical practice

AIM: Patients in clinical practice are relatively vulnerable compared to those enrolled in clinical trials. We focused on analyzing the pattern of regorafenib use in routine clinical practice, which included initial starting dose and follow-up schedule. We also evaluated the efficacy and safety acco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Onco Targets Ther
Main Authors: Yoon, Sang Eun, Lee, Su Jin, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Lim, Ho Yeong, Kang, Won Ki, Park, Young Suk, Kim, Seung Tae
Formato: Artigo
Idioma:Inglês
Publicado: Dove Medical Press 2018
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6309775/
https://ncbi.nlm.nih.gov/pubmed/30636885
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S187621
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares